[慢性便秘治疗模式的转变和基于证据的进展]
概括
新的慢性便秘治疗方法包括改变生活方式,便微生物种移植 (FMT),神经神经调节 (SNM) 和先进的手术选择. 虽然一些疗法显示出前景,但为了标准化和长期有效性,需要进一步的研究.
科学领域:
- 胃肠病学 胃肠病学
- 结肠直肠手术 结肠直肠手术
- 神经胃肠病学 神经胃肠病学
背景情况:
- 慢性便秘管理正在发展,超越了传统的药物治疗和手术.
- 新兴的疗法包括便微生物种移植 (FMT),神经神经调节 (SNM),针和生物反.
- 外科干预也在针对特定疾病,如内部直肠 (IRP) 和缓慢过渡便秘 (STC) 进行.
研究的目的:
- 审查慢性便秘治疗的最新进展.
- 评估新型治疗策略的有效性和潜力.
- 讨论治疗慢性便秘的综合方法.
主要方法:
- 关于慢性便秘治疗的高质量研究的文献综述.
- 分析新兴技术,如FMT,SNM,针,生物反和外科手术程序.
- 传统和综合治疗模式的比较.
主要成果:
- FMT显示了便频率和稳定性的部分改善,但需要标准化和长期验证.
- 在慢性便秘方面,SNM的有效性和成本效益有限.
- 生物反疗法是指导方针推的异能排便 (DD) 的第一线治疗方法.
- laparoscopic 腹腔直肠切除术 (VMR) 对于IRP和直肠切除术 (RC) 越来越受青.
- 整体切除术与大肠直肠解剖仍然是STC的标准,作为替代方案,进行亚整体切除术.
结论:
- 慢性便秘的治疗环境正在向综合战略转变.
- 像FMT和生物反这样的新疗法显示出希望,但需要进一步验证.
- 手术选择正在不断发展,VMR和胆管切除术的变化提供了明显的优势.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
676
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
676
Drugs for Treatment of Diarrhea-Predominant IBS
598
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
598
Chronic Bowel Disorders: Introduction
732
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
732
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
508
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
508
Drugs Affecting GI Tract Motility: Other Laxatives
983
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
983
Inflammatory Bowel Disease V: Surgical Management
424
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
424


